Yi Liu

Also affiliated with King's College London, Second Affiliated Hospital of Dalian Medical University

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “LSD1 inhibition sustains T cell invigoration with a durable response to PD-1 blockade”.

LSD1 inhibition sustains T cell invigoration with a durable response to PD-1 blockade

Nature Communications(2021)10.1038/s41467-021-27179-7

N/A

0DataRank · unranked

91 citations

Brian Debo, Mingfeng Li, Zhennan Shi, Wanqiang Sheng, Yang Shi +1 more

Simultaneous Inhibition of LSD1 and TGFβ Enables Eradication of Poorly Immunogenic Tumors with Anti–PD-1 Treatment

Cancer Discovery(2021)10.1158/2159-8290.cd-20-0017

N/A

0DataRank · unranked

62 citations

Yi Liu, Damayanti Chakraborty, Brian Debo, Yang Shi, Wanqiang Sheng

Distinct spatial immune microlandscapes are independently associated with outcomes in triple-negative breast cancer

Nature Communications(2023)10.1038/s41467-023-37806-0

N/A

0DataRank · unranked

44 citations

Saranya Chumsri, Douglas Hinerfeld, Yaohua Ma, Xue Wang, David Zahrieh +21 more

Interferon signaling and outcomes in triple-negative breast cancer (TNBC) in FinXX, CALGB 40603 (Alliance) and real-world clinico-genomic data.

Journal of Clinical Oncology(2025)10.1200/jco.2025.43.16_suppl.569

N/A

0DataRank · unranked

0 citations

Yi Liu, Sachin Kumar Deshmukh, Jodi M. Carter, Heikki Joensuu, Roberto A. Leon‐Ferre +15 more